CLDN18.2 and 4-1BB bispecific antibody givastomig exerts antitumor activity through CLDN18.2-expressing tumor-directed T-cell activation
1. 系统已在2026-07-30 19:57:13对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: DOI: 10.1136/jitc-2023-006704
文献链接: https://jitc.bmj.com/lookup/doi/10.1136/jitc-2023-006704
其他信息:
出版社: BMJ
作者: Jing Gao; Zhengyi Wang; Wenqing Jiang; Yanni Zhang; Zhen Meng; Yanling Niu; Zhen Sheng; Chan Chen; Xuejun Liu; Xi Chen; Chanjuan Liu; Keren Jia; Cheng Zhang; Haiyan Liao; Jaeho Jung; Eunsil Sung; Hyejin Chung; Jingwu Z. Zhang; Andrew X. Zhu; Lin Shen

